A detailed history of National Asset Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, National Asset Management, Inc. holds 58,722 shares of ABT stock, worth $6.6 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
58,722
Previous 64,704 9.25%
Holding current value
$6.6 Million
Previous $7.35 Million 17.04%
% of portfolio
0.16%
Previous 0.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

SELL
$100.73 - $112.44 $602,566 - $672,616
-5,982 Reduced 9.25%
58,722 $6.1 Million
Q1 2024

May 16, 2024

BUY
$109.52 - $120.96 $889,959 - $982,920
8,126 Added 14.36%
64,704 $7.35 Million
Q4 2023

Mar 15, 2024

SELL
$90.19 - $110.4 $732,883 - $897,110
-8,126 Reduced 12.56%
56,578 $6.23 Million
Q3 2023

Dec 01, 2023

SELL
$95.53 - $114.62 $13.1 Million - $15.8 Million
-137,628 Reduced 68.02%
64,704 $6.27 Million
Q2 2023

Jul 27, 2023

BUY
$100.78 - $112.29 $14.4 Million - $16.1 Million
143,082 Added 241.49%
202,332 $22.1 Million
Q1 2023

May 17, 2023

BUY
$96.86 - $114.01 $40,971 - $48,226
423 Added 0.72%
59,250 $6 Million
Q4 2022

Mar 15, 2023

SELL
$95.06 - $111.52 $100,668 - $118,099
-1,059 Reduced 1.77%
58,827 $6.46 Million
Q4 2022

Feb 21, 2023

SELL
$95.06 - $111.52 $41,351 - $48,511
-435 Reduced 0.72%
59,886 $6.58 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $1.76 Million - $2.04 Million
18,165 Added 43.09%
60,321 $5.84 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $84,616 - $102,273
-829 Reduced 1.93%
42,156 $4.58 Million
Q1 2022

May 02, 2022

SELL
$114.02 - $139.04 $326,325 - $397,932
-2,862 Reduced 6.24%
42,985 $5.09 Million
Q4 2021

Jan 28, 2022

BUY
$115.53 - $141.46 $102,128 - $125,050
884 Added 1.97%
45,847 $6.45 Million
Q3 2021

Nov 16, 2021

SELL
$116.66 - $129.06 $1.1 Million - $1.22 Million
-9,437 Reduced 17.35%
44,963 $5.31 Million
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $312,821 - $368,235
-2,957 Reduced 5.16%
54,400 $6.31 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $995,994 - $1.17 Million
-9,151 Reduced 13.76%
57,357 $6.88 Million
Q4 2020

Feb 04, 2021

SELL
$105.0 - $114.42 $1.94 Million - $2.12 Million
-18,489 Reduced 21.75%
66,508 $7.28 Million
Q3 2020

Nov 09, 2020

SELL
$91.64 - $111.29 $13,012 - $15,803
-142 Reduced 0.17%
84,997 $9.25 Million
Q2 2020

Jul 31, 2020

BUY
$76.57 - $98.0 $2.79 Million - $3.57 Million
36,380 Added 74.61%
85,139 $7.79 Million
Q1 2020

May 06, 2020

BUY
$62.82 - $91.86 $302,478 - $442,305
4,815 Added 10.96%
48,759 $3.85 Million
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $1.26 Million - $1.41 Million
16,078 Added 57.7%
43,944 $3.82 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $516,492 - $560,038
6,311 Added 29.28%
27,866 $2.33 Million
Q2 2019

Aug 05, 2019

BUY
$72.88 - $85.0 $77,908 - $90,865
1,069 Added 5.22%
21,555 $1.82 Million
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $76,219 - $92,149
-1,151 Reduced 5.32%
20,486 $1.64 Million
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $16,193 - $18,344
247 Added 1.15%
21,637 $1.57 Million
Q3 2018

Nov 08, 2018

BUY
$60.81 - $73.36 $45,546 - $54,946
749 Added 3.63%
21,390 $1.57 Million
Q2 2018

Oct 05, 2018

BUY
$57.57 - $63.54 $748 - $826
13 Added 0.06%
20,641 $1.26 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $45,747 - $51,723
-813 Reduced 3.79%
20,628 $1.24 Million
Q4 2017

Feb 15, 2018

BUY
$53.68 - $57.47 $6,871 - $7,356
128 Added 0.6%
21,441 $1.23 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $43,254 - $48,276
900 Added 4.41%
21,313 $1.14 Million
Q2 2017

Aug 15, 2017

BUY
N/A
20,413
20,413 $993,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.